NCT07286318 2026-02-19
A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients
University of Pittsburgh
Phase EARLY_PHASE1 Not yet recruiting
Clinical Trials
11 trialsNCT05358938 2026-02-06
Exercise to Boost Response to Checkpoint Blockade Immunotherapy
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Active not recruiting
NCT03543969 2026-02-05
Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Active not recruiting
NCT05651828 2026-01-29
Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Recruiting
NCT06664151 2025-10-02
A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcinoma (CSCC) Patients Awaiting Curative Excision
Dana-Farber Cancer Institute
Phase EARLY_PHASE1 Recruiting
NCT04630886 2024-11-19
Use of Tranexamic Acid in Reduction of Post-Op Complications in Mohs Micrographic Surgery
University of Massachusetts, Worcester
Phase EARLY_PHASE1 Terminated
NCT05702398 2023-01-27
Pilot Trial of Supplemental Vitamin A and Nicotinamide
Rhode Island Hospital
Phase EARLY_PHASE1 Unknown
NCT02120677 2020-12-16
Topical Itraconazole in the Treatment of Basal Cell Carcinoma
Johns Hopkins University
Phase EARLY_PHASE1 Completed
NCT00663910 2017-01-02
Topical Aminolevulinic Acid in Patients With Nonmelanoma Skin Cancer
The Cleveland Clinic
Phase EARLY_PHASE1 Terminated
NCT01425749 2016-04-04
Mel55
University of Virginia
Phase EARLY_PHASE1 Completed
NCT00535769 2012-07-20
Evaluation of Adherence to Topical Agents: Applying Communication Technology to Improve Sunscreen Use
Massachusetts General Hospital
Phase EARLY_PHASE1 Completed